Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Surgery
Published in: BMC Surgery 1/2022

Open Access 01-12-2022 | Rectal Cancer | Research article

Laparoscopic extralevator abdominoperineal excision in distal rectal cancer patients: a retrospective comparative study

Authors: Zhiqiang Wang, Rui Liang, Dilimulati Yalikun, Jun Yang, Wenliang Li, Zhiyong Kou

Published in: BMC Surgery | Issue 1/2022

Login to get access

Abstract

Background

At present, abdominoperineal excision with neoadjuvant chemoradiotherapy (nCRT) is one of the treatment modalities of distal rectal cancer. Our study analyzed the effects of laparoscopic extralevator abdominoperineal resection (ELAPE) compared with laparoscopic conventional abdominoperineal resection(cAPR) in the treatment of distal rectal cancer.

Methods

Retrospective analysis was conducted on the clinicopathological data of 177 distal rectal cancer patients treated with a laparoscopic abdominoperineal resection between 2011 and 2018. The patients were divided into four groups as follows: ELAPE without nCRT (group A), cAPR without nCRT (group B), ELAPE with long-course nCRT (group C) and cAPR with long-course nCRT (group D).

Results

Positive circumferential resection margin (CRM), local recurrence rate, 3-year disease-free survival (DFS) and 3-year overall survival (OS) did not differ between group A and group B. The rate of positive CRM in group C was lower than group D (4.4% vs. 11.9%, respectively), although the difference was not significant (P = 0.377). The 3-year local recurrence rate in group C was lower compared with group D (6.6% vs. 16.7%, respectively), although the difference was not significant (P = 0.135). Three-year DFS and 3-year OS were not different between groups C and D.

Conclusions

This study showed that the effect of laparoscopic ELAPE in patients with low-risk rectal cancer is similar to laparoscopic cAPR, revealing that laparoscopic cAPR can be routinely selected for patients with low-risk rectal cancer. Furthermore, laparoscopic ELAPE has a tendency to reduce the rate of positive CRM and local recurrence in patients with high-risk rectal cancer. Laparoscopic ELAPE can be routinely considered for patients with high-risk rectal cancer.
Literature
1.
Zhang X, Wu Q, Hu T, Gu C, Bi L, Wang Z. Laparoscopic versus conventional open abdominoperineal resection for rectal cancer: an updated systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A. 2018;28(5):526–39.CrossRef
2.
Peltrini R, Imperatore N, Carannante F, Cuccurullo D, Capolupo GT, Bracale U, et al. Age and comorbidities do not affect short-term outcomes after laparoscopic rectal cancer resection in elderly patients. A multi-institutional cohort study in 287 patients. Updates Surg. 2021;73(2):527–37.CrossRef
3.
Schnitzbauer V, Gerken M, Benz S, Völkel V, Draeger T, Fürst A, et al. Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort. Surg Endosc. 2020;34(3):1132–41.CrossRef
4.
Atallah C, Efron JE. Laparoscopy for rectal cancer. Clin Colon Rectal Surg. 2017;30(2):104–11.CrossRef
5.
Xiao H, Huang R, Li X, Wang Z. Laparoscopic versus open extralevaor abdominoperineal excision for lower rectal cancer: a retrospective cohort study in single institute. J Laparoendosc Adv Surg Tech A. 2021;31(1):71–6.CrossRef
6.
Yang X, Jin C, Deng X, Wang M, Zhang Y, Wei M, et al. Laparoscopic extralevator abdominoperineal excision of the rectum with primary suturing: short-term outcomes from single-institution study. J Laparoendosc Adv Surg Tech A. 2016;26(1):40–6.CrossRef
7.
Zhou X, Sun T, Xie H, Zhang Y, Zeng H, Fu W. Extralevator abdominoperineal excision for low rectal cancer: a systematic review and meta-analysis of the short-term outcome. Colorectal Dis. 2015;17(6):474–81.CrossRef
8.
West NP, Anderin C, Smith KJE, Holm T, Quirke P, European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010;97(4):588–99.CrossRef
9.
Lehtonen T, Räsänen M, Carpelan-Holmström M, Lepistö A. Oncological outcomes before and after the extralevator abdominoperineal excision in a single centre, high volume unit. Colorectal Dis. 2019;21(2):183–90.CrossRef
10.
Erlandsson J, Lörinc E, Ahlberg M, Pettersson D, Holm T, Glimelius B, et al. Tumour regression after radiotherapy for rectal cancer—results from the randomised Stockholm III trial. Radiother Oncol. 2019;135:178–86.CrossRef
11.
Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, et al. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol. 2019;25(33):4850–69.CrossRef
12.
Akgun E, Ozkok S, Tekin M, Yoldas T, Caliskan C, Kose T, et al. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. World J Surg Oncol. 2017;15(1):205.CrossRef
13.
Goldenberg BA, Holliday EB, Helewa RM, Singh H. Rectal Cancer in 2018: a primer for the gastroenterologist. Am J Gastroenterol. 2018;113(12):1763–71.CrossRef
14.
Maguire A, Sheahan K. Controversies in the pathological assessment of colorectal cancer. World J Gastroenterol. 2014;20(29):9850–61.CrossRef
15.
Li Y, Wang J, Ma X, Tan L, Yan Y, Xue C, et al. A review of neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Int J Biol Sci. 2016;12(8):1022–31.CrossRef
16.
Qi X, Liu M, Tan F, Xu K, Yao Z, Zhang N, et al. Laparoscopic extralevator abdominoperineal resection versus laparoscopic abdominoperineal resection for lower rectal cancer: a retrospective comparative study from China. Int J Surg. 2019;71:158–65.CrossRef
17.
Klein M, Fischer A, Rosenberg J, Gögenur I, Danish Colorectal Cancer Group (DCCG). Extralevatory Abdominoperineal excision (ELAPE) does not result in reduced rate of tumor perforation or rate of positive circumferential resection margin: a nationwide database study. Ann Surg. 2015;261(5):933–8.CrossRef
18.
Zhang H, Li G, Cao K, Zhai Z, Wei G, Ye C, et al. Long-term outcomes after extra-levator versus conventional abdominoperineal excision for low rectal cancer. BMC Surg. 2022;22(1):242.CrossRef
19.
Shen Y, Yang T, Zeng H, Meng W, Wang Z. Efficacy of pelvic peritoneum closure after laparoscopic extralevator abdominoperineal excision for rectal cancer. J Gastrointest Surg. 2021;25(10):2668–78.CrossRef
20.
Liu B, Farquharson J. The quality of lymph node harvests in extralevator abdominoperineal excisions. BMC Surg. 2020;20(1):241.CrossRef
21.
Tao Y, Han JG, Wang ZJ. Extralevator abdominoperineal excision for advanced low rectal cancer: where to go. World J Gastroenterol. 2020;26(22):3012–23.CrossRef
22.
Qi XY, Cui M, Liu MX, Xu K, Tan F, Yao ZD, et al. Extralevator abdominoperineal excision versus abdominoperineal excision for low rectal cancer: a meta-analysis. Chin Med J (Engl). 2019;132(20):2446–56.CrossRef
23.
Hanif Z, Bradley A, Hammad A, Mukherjee A. Extralevator abdominoperineal excision (Elape): a retrospective cohort study. Ann Med Surg (Lond). 2016;10:32–5.CrossRef
24.
Moore TJ, Moran BJ. Precision surgery, precision terminology: the origins and meaning of ELAPE. Colorectal Dis. 2012;14(10):1173–4.CrossRef
25.
Neşşar G, Demirbağ AE, Celep B, Elbir OH, Kayaalp C. Extralevator abdominoperineal excision versus conventional surgery for low rectal cancer: a single surgeon experience. Ulus Cerrahi Derg. 2016;32(4):244–7.
26.
Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics. 2019;39(2):367–87.CrossRef
27.
Moreno CC, Sullivan PS, Mittal PK. Rectal MRI for cancer staging and surveillance. Gastroenterol Clin North Am. 2018;47(3):537–52.CrossRef
28.
Rafaelsen SR, Vagn-Hansen C, Sørensen T, Lindebjerg J, Pløen J, Jakobsen A. Elastography and diffusion-weighted MRI in patients with rectal cancer. Br J Radiol. 2015;88(1056):20150294.CrossRef
Metadata
Title
Laparoscopic extralevator abdominoperineal excision in distal rectal cancer patients: a retrospective comparative study
Authors
Zhiqiang Wang
Rui Liang
Dilimulati Yalikun
Jun Yang
Wenliang Li
Zhiyong Kou
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2022
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-022-01865-9

Other articles of this Issue 1/2022

BMC Surgery 1/2022 Go to the issue

Research

Study on the influence of balloon dilation mode on the intravertebral cleft of osteoporotic fracture

Research

Effect of radical lymphadenectomy in colorectal cancer with para-aortic lymph node metastasis: a systematic review and meta-analysis

Research

Identification of risk factors for postoperative stage 3 acute kidney injury in patients who received surgical repair for acute type A aortic dissection

Research

Chylous ascites with lymphatic leakage localization: technical aspects and clinical applications

Research

Breast conserving therapy for central breast cancer in the United States

Research

Laparoscopic surgery does not reduce the need for red blood cell transfusion after resection for colorectal tumour: a propensity score match study on 728 patients